Andréa Freirias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andréa Freirias has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- André Fernandes Reis
Laboratory of Molecular and Translacional Endocrinology, Universidade Federal de São Paulo (UNIFESP), Brazil; Diabetes Center, Universidade Federal de São Paulo (UNIFESP), Brazil
1 shared publication - Cecília Attux
Department of Psychiatry, Universidade Federal de São Paulo. Rua Machado Bitencourt, 222, Vila Clementino, CEP 04044-000, São Paulo, (SP), Brazil
1 shared publication - Hélio Elkis
Department and Institute of Psychiatry, University of São Paulo Medical School. Rua Dr. Ovídio Pires de Campos, 785 – Cerqueira César, CEP 05403010, São Paulo, (SP), Brazil
1 shared publication - Jair de Jesus Mari
Universidade Federal de São Paulo
1 shared publication - Larissa Campagna Martini
Universidade Federal de São Carlos, Brasil
1 shared publication - Maria das Graças Miquelutti Camargo
Department and Institute of Psychiatry, University of São Paulo Medical School. Rua Dr. Ovídio Pires de Campos, 785 – Cerqueira César, CEP 05403010, São Paulo, (SP), Brazil
1 shared publication
Latest Publications
- Open Access
- 18 February 2013
- Published by Springer Nature in BMC Psychiatry
- Vol. 13 (1) , 60
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
Patients with schizophrenia have lower longevity than the general population as a consequence of a combination of risk factors connected to the disease, lifestyle and the use of medications, which are related to weight gain. A multicentric, randomized, controlled-trial was conducted to test the efficacy of a 12-week group Lifestyle Wellness Program (LWP). The program consists of a one-hour weekly session to discuss topics like dietary choices, lifestyle, physical activity and self-esteem with patients and their relatives. Patients were randomized into two groups: standard care (SC) and standard care plus intervention (LWP). Primary outcome was defined as the weight and body mass index (BMI). 160 patients participated in the study (81 in the intervention group and 79 in the SC group). On an intent to treat analysis, after three months the patients in the intervention group presented a decrease of 0.48 kg (CI 95% -0.65 to 1.13) while the standard care group showed an increase of 0.48 kg (CI 95% 0.13 to 0.83; p=0.055). At six-month follow-up, there was a significant weight decrease of −1.15 kg, (CI 95% -2.11 to 0.19) in the intervention group compared to a weight increase in the standard care group (+0.5 kg, CI 95% -0.42–1.42, p=0.017). In conclusion, this was a multicentric randomized clinical trial with a lifestyle intervention for individuals with schizophrenia, where the intervention group maintained weight and presented a tendency to decrease weight after 6 months. It is reasonable to suppose that lifestyle interventions may be important long-term strategies to avoid the tendency of these individuals to increase weight. NCT01368406
- 18 February 2013
- Published by Springer Nature in BMC Psychiatry
- Vol. 13 (1) , 60
Open AccessA 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
Patients with schizophrenia have lower longevity than the general population as a consequence of a combination of risk factors connected to the disease, lifestyle and the use of medications, which are related to weight gain. A multicentric, randomized, controlled-trial was conducted to test the efficacy of a 12-week group Lifestyle Wellness Program (LWP). The program consists of a one-hour weekly session to discuss topics like dietary choices, lifestyle, physical activity and self-esteem with patients and their relatives. Patients were randomized into two groups: standard care (SC) and standard care plus intervention (LWP). Primary outcome was defined as the weight and body mass index (BMI). 160 patients participated in the study (81 in the intervention group and 79 in the SC group). On an intent to treat analysis, after three months the patients in the intervention group presented a decrease of 0.48 kg (CI 95% -0.65 to 1.13) while the standard care group showed an increase of 0.48 kg (CI 95% 0.13 to 0.83; p=0.055). At six-month follow-up, there was a significant weight decrease of −1.15 kg, (CI 95% -2.11 to 0.19) in the intervention group compared to a weight increase in the standard care group (+0.5 kg, CI 95% -0.42–1.42, p=0.017). In conclusion, this was a multicentric randomized clinical trial with a lifestyle intervention for individuals with schizophrenia, where the intervention group maintained weight and presented a tendency to decrease weight after 6 months. It is reasonable to suppose that lifestyle interventions may be important long-term strategies to avoid the tendency of these individuals to increase weight. NCT01368406